U.S. markets closed

AcelRx Pharmaceuticals, Inc. (ACRX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.2600-0.0100 (-0.79%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 7/24/2021
Current
3/31/202112/31/20209/30/20206/30/2020
Market Cap (intraday) 5
150.07M202.48M122.53M128.48M97.88M
Enterprise Value 3
103.09M185.19M107.15M114.99M75.33M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
21.2726.7619.7525.8439.92
Price/Book (mrq)
N/AN/AN/AN/AN/A
Enterprise Value/Revenue 3
18.61362.40145.1984.0625.76
Enterprise Value/EBITDA 7
-3.61-23.64-13.77-15.10-12.41

Trading Information

Stock Price History

Beta (5Y Monthly) 0.93
52-Week Change 30.80%
S&P500 52-Week Change 336.19%
52 Week High 32.9400
52 Week Low 31.0200
50-Day Moving Average 31.3721
200-Day Moving Average 31.6190

Share Statistics

Avg Vol (3 month) 32.28M
Avg Vol (10 day) 32.29M
Shares Outstanding 5119.1M
Implied Shares Outstanding 6N/A
Float 116.83M
% Held by Insiders 11.93%
% Held by Institutions 134.71%
Shares Short (Jun 29, 2021) 410.83M
Short Ratio (Jun 29, 2021) 44.91
Short % of Float (Jun 29, 2021) 49.21%
Short % of Shares Outstanding (Jun 29, 2021) 49.09%
Shares Short (prior month May 27, 2021) 413.73M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-618.25%

Management Effectiveness

Return on Assets (ttm)-26.00%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)5.54M
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)32.40%
Gross Profit (ttm)-4.63M
EBITDA -32.44M
Net Income Avi to Common (ttm)-33.41M
Diluted EPS (ttm)-0.3570
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)67.34M
Total Cash Per Share (mrq)0.56
Total Debt (mrq)20.37M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.59
Book Value Per Share (mrq)-0.23

Cash Flow Statement

Operating Cash Flow (ttm)-33.85M
Levered Free Cash Flow (ttm)-19.22M